Page last updated: 2024-11-04

sulfasalazine and Orphan Diseases

sulfasalazine has been researched along with Orphan Diseases in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Orphan Diseases: Rare diseases that have not been well studied.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hsing, YE1
Walker, J1
Hoversten, P1
Beachey, J1
Pham, M1
Bhagra, A1

Other Studies

2 other studies available for sulfasalazine and Orphan Diseases

ArticleYear
Bilateral interstitial keratitis with anterior stromal infiltrates associated with reactive arthritis.
    BMJ case reports, 2017, Jul-06, Volume: 2017

    Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Corneal Strom

2017
A rare cause of oligoarthritis with septic presentation.
    BMJ case reports, 2018, Apr-17, Volume: 2018

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Reactive; Diarrhea; Dysuria; Fever; Gastr

2018